Skip to Content

Brain Malformation Testing

Complex cortical dysplasia with other brain malformations (CDCBM) is a neuronal migration disorder associated with axon guidance defects.  Clinically, patients have mild to severe mental retardation, strabismus, axial hypotonia, and spasticity.  Cortical malformations seen on brain MRI include: polymicrogyria, gyral disorganization, fusion of the basal ganglia, thin corpus callosum, hypoplastic brainstem, and abnormal cerebellar vermis.   

Abnormalities of the TUBB3 gene were reported in approximately 10% (12/120) of patients with CDCBM. 

Similar to other types of pontocerebellar hypoplasias (PCH), subtypes PCH2 (OMIM 277470) and PCH4 (OMIM 225753) are characterized by small cerebellum and brainstem, variable neocortical atrophy, and abnormal mental and motor development.  In addition, patients with PCH2 exhibit progressive microcephaly from birth, extrapyramidal dyskinesia, chorea, and epilepsy.  PCH4, also known as fatal infantile olivopontocerebellar hypoplasia, is associated with a more severe course and an earlier lethality than PCH2. Four patients with PCH2 have also been described with homozygous missense mutations in two of the three other noncatalytic subunits of the tRNA-splicing endonuclease complex, TSEN2 [OMIM 608753] and TSEN34 [OMIM 608754] [2]. 

Our Tier 2 PCH panel includes full gene sequencing of the TSEN2 and TSEN34 genes. 

Similar to other types of pontocerebellar hypoplasias (PCH), subtypes PCH2 (OMIM 277470) and PCH4 (OMIM 225753) are characterized by small cerebellum and brainstem, variable neocortical atrophy, and abnormal mental and motor development.  In addition, patients with PCH2 exhibit progressive microcephaly from birth, extrapyramidal dyskinesia, chorea, and epilepsy.  PCH4, also known as fatal infantile olivopontocerebellar hypoplasia, is associated with a more severe course and an earlier lethality than PCH2.  Mutations in TSEN54 [OMIM 608755], encoding one of the noncatalytic subunits of the tRNA-splicing endonuclease complex, have recently been implicated in the etiology of PCH2A and PCH4.  Budde et al (2008) sequenced the TSEN54 gene in 58 patients from the Netherlands and other European countries, Brazil, and Israel.  3/3 patients with PCH4 had mutations detected in TSEN54, and 47/52 patients with PCH2 were homozygous for the p.A307S mutation.  Of these 47 patients, 31 shared European ancestry and a haplotype on which p.A307S arose as a founder mutation.

To date no deletions or duplications involving the TSEN54 gene as causative of pontocerebellar hypoplasia have been reported.

The hallmark features seen in patients with OPHN1 mutations include moderate to severe mental retardation and cerebellar hypoplasia [OMIM #300486], particularly cerebellar vermis hypoplasia (CVH).  CVH may also be called “Dandy-Walker variant” due to the phenotypic overlap with Dandy-Walker malformation (DWM).   Physical findings may include tall stature, macrocephaly, and common facial features such as prominent supraorbital ridges, hypotelorism, deep-set eyes, long tubular nose, short philtrum, thin upper lip and prominent chin.  Hypotonia and developmental delay are noticed in most patients in early childhood, who then develop moderate to severe mental retardation.   Mutations of the OPHN1 [OMIM #300127] gene, or oligophrenin-1, have been identified in patients with X-linked mental retardation with cerebellar hypoplasia.  Philip N, et al [2003] reported that 2/6 (33%) males with moderate mental retardation and CVH had mutations in OPHN1.  Zanni G, et al [2005] found that 2/17 (12%) males with mental retardation and cerebellar anomalies had OPHN1 mutations.

Deletions and/or duplications of the OPHN1 gene as causative of disease have been reported.

Bilateral frontoparietal polymicrogyria (BFPP) [OMIM #606854] is characterized by moderate-severe mental retardation, seizures, dysconjugate gaze, and characteristic radiological findings.  Mutations of the GPR56 [OMIM #604110] gene, or G-protein coupled receptor 56, have been identified in patients with BFPP.   Piao X, et al [2005] studied patients with BFPP along with some patients with other polymicrogyria syndromes.  All 29 patients with BFPP were found to be homozygous for GPR56 mutations.  However, no patients without the BFPP cortical distribution or without both white matter and posterior fossa changes were found to mutations in GPR56.

Deletions and/or duplications of the GPR56 gene as causative of disease have been reported.

DCX [OMIM#300121] abnormalities result in severe lissencephaly or SBH in boys, but a less severe SBH in girls.  DCX abnormalities are generally associated with an a>p gradient.  In males, DCX mutations are present in approximately 30% with SBH and approximately 10% with lissencephaly.  In females, DCX mutations are present in approximately 80% with SBH, especially those with diffuse bands or bilateral frontal only bands.  Intragenic deletions of the DCX gene are present in approximately 10% of female patients with SBH in whom no mutations were identified by DCX sequencing.

Dr. William Dobyns at the Seattle Children’s Research Institute is available to review MRI scans and give recommendations regarding genetic testing.  Please contact Dr. Dobyns (wbd@uw.edu) or his coordinator, Hailly Butler (hailly.butler@seattlechildrens.org) to arrange this, if desired. 

Severe, de novo phenotype in females:  X-linked mental retardation and microcephaly with pontine and cerebellar hypoplasia [OMIM #300749] is characterized by severe or profound mental retardation (MR), microcephaly, and disproportionate pontine and cerebellar hypoplasia in females.  These mutations are typically de novo and thought to be lethal in males.

Mild, familial phenotype in males:  Affected males have mild to moderate MR, and carrier females seem to be unaffected.  In 2 families, MR was accompanied by nystagmus in multiple affected individuals.

CASK mutations were detected in 4/46 individuals with MIC-PCH including 3/13 females and 1/33 males.   A resequencing screen of X-chromosome coding exons in individuals from approximately 350 families with X-linked MR revealed CASK mutations in 4 families.

Deletions and/or duplications of the CASK gene as causative of disease have been reported.

Autosomal recessive primary microcephaly (MCPH) is characterized by:

  • congenital microcephaly (3 SD below the mean at birth or at least 4 SD below the mean at later ages)
  • mental retardation, but no other neurological findings (febrile or other mild seizures do not exclude the diagnosis)
  • normal or mildly short stature that is less severe than the markedly small head circumference
  • normal weight and appearance except for the microcephaly

Mutations in the ASPM [OMIM #605481] gene are the most common cause of MCPH.  Approximately 40% of patients (both consanguineous and non-consanguineous) with a strict diagnosis of MCPH have mutations in ASPM.

Deletions and/or duplications of the ASPM gene as causative of microcephaly have been reported.

Contact The Foundation for Children with Microcephaly (www.childrenwithmicro.org) for more information and support

The hallmark feature seen in patients with TUBB2B mutations is asymmetric polymicrogyria (PMG). PMG is a brain malformation with numerous small gyri separated by shallow sulci, creating a cobblestone appearance.  PMG in these patients is usually bilateral, asymmetric, and more striking in the frontal and temporal lobes.  Other findings on MRI include absence of the corpus callosum, abnormal basal ganglia and cerebellum, and hypoplasia of the brainstem.  Most patients also have microcephaly, severe mental retardation and seizures.   

Mutations of the TUBB2B gene have been identified in patients with asymmetrical PMG. Jaglin XH, et al [2009] reported four unrelated individuals and one fetus with asymmetrical PMG and de novo mutations in TUBB2BAll mutations were missense mutations in highly conserved residues in exon 4.  These mutations result in haploinsufficiency and aberrant heterodimer assembly.   Mutations in TUBB2B are autosomal dominant and all mutations, to date, have been de novo.  

Severe, de novo phenotype in females:  X-linked mental retardation and microcephaly with pontine and cerebellar hypoplasia [OMIM #300749] is characterized by severe or profound mental retardation (MR), microcephaly, and disproportionate pontine and cerebellar hypoplasia in females.  These mutations are typically de novo and thought to be lethal in males.

Mild, familial phenotype in males:  Affected males have mild to moderate MR, and carrier females seem to be unaffected.  In 2 families, MR was accompanied by nystagmus in multiple affected individuals.

CASK mutations were detected in 4/46 individuals with MIC-PCH including 3/13 females and 1/33 males.   A resequencing screen of X-chromosome coding exons in individuals from approximately 350 families with X-linked MR revealed CASK mutations in 4 families.

Syndicate content

Newsletter

Join Our Mailing List
Email:
For Email Marketing you can trust